Krystal Biotech, Inc. ($KRYS)
Filing Information
| Accession Number | 0001711279-26-000023 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
11,803
Total Value
$3,252,824.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 27, 2026 | Sale | 9,430 | $275.45 | $2,597,481.24 | 75,666 | Indirect | Directly beneficially owned by Alta Bioequities, L.P. | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Sale | 2,373 | $276.17 | $655,343.10 | 73,293 | Indirect | Directly beneficially owned by Alta Bioequities, L.P. | View Details |